INTRODUCTION A slight decrease in blood testosterone level in men is a physiological state associated with the aging. The aim of our study was to evaluate the occurrence of hormone and metabolic disorders, as well as the immunolocalization and immunoexpression of androgen receptors (AR) and estrogen-alpha receptors (ERa) in the prostates of men with benign prostatic hyperplasia (BPH) and coexis...

BACKGROUND/AIM Benign prostatic hyperplasia (BPH) is one of the most common disease among males aging 50 years and more. The rise of the prevalence of BPH is related to aging, and since duration of life time period has the tendency of rising the prevalence of BPH will rise as costs of BPH treatment will and its influence on health economic budget. Dutasteride is a new drug similar to finasterid...

Benign prostatic hyperplasia (BPH) is a urological disease prevalent among the ageing male population, which impairs quality of life, including hyperlipidaemia and decline in renal functions. Combining Anthocleista vogelii Alstonia boonei stem bark extract has effectively managed BPH its associated complications. This study evaluated effects combined (CAASBE) on lipid profile functions rats ind...

Transurethral resection of the prostate (TURP) is the dominant factor in the treatment of benign prostate hyperplasia (BPH). However, Photoselective vaporization of the prostate (PVP) has attracted more attention in the treatment of BPH. Therefore, this article summarized the therapeutic effect of 80 W to 180 W green laser vaporization in the treatment of BPH. The results showed that the PVP ca...

Hypertension and benign prostatic hyperplasia (BPH) are common disorders of aging men. As the world population is aging these two diseases are becoming a significant public health problem worldwide. Approximately 30% of men treated for BPH have coexisting hypertension. The α-Adrenergic Blockers: Prazosin, Terazosin and Doxazosin are established agents in the therapy of hypertension, and are als...

Estrogens and estrogen receptors (ESRs) have been implicated in the stimulation of aberrant prostate growth and the development of prostate diseases. The aim of the present study was to investigate four single nucleotide polymorphisms (SNPs) of the ESR2 gene in order to examine whether ESR2 is a susceptibility gene for benign prostatic hyperplasia (BPH). In order to evaluate whether an associat...